Promising clinical outcomes of sequential and “Sandwich” chemotherapy and extended involved‐field intensity‐modulated radiotherapy in patients with stage I(E)/II(E) extranodal natural killer/T‐cell lymphoma

BACKGROUND: The optimal treatment for the rare subtype of non‐Hodgkin lymphoma, extranodal natural killer/T‐cell lymphoma (ENKTL), nasal‐type, has not been clearly defined. The purpose of the study was to investigate the efficacy of sequential and “Sandwich” chemotherapy and extended involved‐field...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Han‐yu, Niu, Shao‐qing, Yang, Yun‐ying, Li, Yi‐yang, Chen, Hong‐bo, Zhang, Yu‐jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308112/
https://www.ncbi.nlm.nih.gov/pubmed/30484966
http://dx.doi.org/10.1002/cam4.1755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308112/
https://www.ncbi.nlm.nih.gov/pubmed/30484966
http://dx.doi.org/10.1002/cam4.1755

Ejemplares similares